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Many diseases are associated with protein misfolding and
aggregation (1, 2). The aggregation process is often characterized by the presence of one or more threshold concentrations at
which a sharp, discontinuous change to some aspect of the
assembly state (e.g. size, conformational characteristics, mateThis work was supported by National Institutes of Health Grants
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rial properties) occurs (3–6). Such a change can be described
using the concepts of phase transitions. Phase separation, a subcategory of phase transitions, has recently received considerable attention due to increasing recognition of its importance in
cell biology (7–13). Phase separation refers to aggregation-related changes in molecular density that give rise to the coexistence of dilute macromolecule-deficient phases and dense macromolecule-rich phases (3, 14, 15). Examples of multiple
coexisting phases have been observed in biological contexts
(15–18), and these phases can be liquid, solid, or semisolid (e.g.
a gel) (10, 19 –25). Driving forces for phase separation are quantified in terms of saturation concentrations (14, 19, 26). For a
given two-phase system, the saturation concentration is the
bulk concentration of the protein, beyond which the solution
separates into two coexisting phases. The lower the saturation
concentration, the stronger the driving force for aggregation
and phase separation (14, 19, 26 –29).
Ligand binding can alter saturation concentrations and shift
phase boundaries to either stabilize or destabilize specific
phases (30). Wyman and Gill (31) introduced this concept,
known as polyphasic linkage, to interpret the impact of ligands
on saturation concentrations. In the current work, we report
results from our studies of ligand binding to N-terminal fragments of the huntingtin protein (Htt-NTFs).2
Huntington’s disease (HD) is a devastating neurological disorder that affects medium spiny and cerebellar neurons (32).
The age of onset as well as severity of HD are inversely correlated with the length of the polyglutamine (polyQ) tract within
the N-terminal region of huntingtin (Htt) (32). The disease is
characterized by deposition of insoluble intranuclear deposits
of Htt-NTFs with expanded polyQ tracts in afflicted neurons
(33, 34). Htt-NTFs consist of a 17-residue N-terminal stretch
(MATLEKLMKAFESLKSF) designated as N17, a polyQ tract of
length n (Qn), and a 38-residue C-terminal stretch (C38) that
includes two polyproline (polyP) modules, P11 and P10, connected by a 17-residue linker denoted as L17 (QLPQPPPQAQ-

2

The abbreviations used are: Htt-NTF, huntingtin N-terminal fragment; HD,
Huntington’s disease; polyQ, polyglutamine; polyP, polyproline; Qn, polyQ
tract of length n; CFP, cyan fluorescent protein; YFP, yellow fluorescent
protein; ThT, thioflavin T; TEM, transmission electron microscopy; ANOVA,
analysis of variance.
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Huntingtin N-terminal fragments (Htt-NTFs) with expanded
polyglutamine tracts form a range of neurotoxic aggregates that
are associated with Huntington’s disease. Here, we show that
aggregation of Htt-NTFs, irrespective of polyglutamine length,
yields at least three phases (designated M, S, and F) that are
delineated by sharp concentration thresholds and distinct
aggregate sizes and morphologies. We found that monomers
and oligomers make up the soluble M phase, ⬃25-nm spheres
dominate in the soluble S phase, and long, linear fibrils make up
the insoluble F phase. Previous studies showed that profilin, an
abundant cellular protein, reduces Htt-NTF aggregation and
toxicity in cells. We confirm that profilin achieves its cellular
effects through direct binding to the C-terminal proline-rich
region of Htt-NTFs. We show that profilin preferentially binds
to Htt-NTF M-phase species and destabilizes aggregation and
phase separation by shifting the concentration boundaries for
phase separation to higher values through a process known
as polyphasic linkage. Our experiments, aided by coarse-grained
computer simulations and theoretical analysis, suggest that preferential binding of profilin to the M-phase species of Htt-NTFs is
enhanced through a combination of specific interactions between
profilin and polyproline segments and auxiliary interactions
between profilin and polyglutamine tracts. Polyphasic linkage may
be a general strategy that cells utilize to regulate phase behavior of
aggregation-prone proteins. Accordingly, detailed knowledge of
phase behavior and an understanding of how ligands modulate
phase boundaries may pave the way for developing new therapeutics against a variety of aggregation-prone proteins.

Modulation of Htt-NTF aggregation via polyphasic linkage
Results
C38 is necessary for profilin to bind to Htt-NTFs
Shao et al. (51) previously identified unphosphorylated profilin as an intracellular ligand that reduces Htt-NTF aggregation and toxicity. In that study, a direct interaction was inferred
from pulldowns between non-mutant Htt-NTF (Q25) and
either wildtype profilin or profilin variants with a mutated
polyP binding pocket. The results indicated that the polyP
binding pocket of profilin is essential for binding Htt-NTFs. We
carried out follow-up experiments to assess, directly, whether
the Htt-NTF C38 stretch is essential to elicit profilin-dependent reduction in aggregation. We used an intracellular aggregation assay (51, 53–55) to quantify the impact of profilin overexpression on the aggregation of constructs with and without
the C38 stretch. Htt-NTFs with expanded polyQ tracts (Q72)
were fused to cyan (CFP) or yellow fluorescent proteins (YFP).
CFP and YFP are used as FRET pairs, and when fused to HttNTFs they serve as intracellular reporters of aggregation. We
expressed N17-Q72-C38-CFP/YFP or N17-Q72-CFP/YFP in
HEK293 cells cultured in a 96-well format (51), with or without
profilin. We incubated the cells for 48 h before fixing the plates
in 2% paraformaldehyde and measuring intracellular, intermolecular FRET in a fluorescence plate reader. As described previously (51), wildtype profilin reduced N17-Q72-C38-CFP/YFP
aggregation by 30%. However, when the polyP-containing C38
stretch was removed, the aggregation of N17-Q72-CFP/YFP
was unaffected by profilin overexpression (see first and second
green bars in Fig. S1). The ability to suppress intracellular aggregation by profilin was blocked by the phosphomimic mutation
S137D and was preserved by the S137A mutation (second and
third gray bars, respectively, in Fig. S1), whereas these mutations had no effects on constructs lacking C38 (green bars in Fig.
S1). These data confirm that direct interactions between profilin and polyP modules in C38 play a central role in the modulation of Htt-NTF aggregation via profilin binding.
Constructs for in vitro experiments
Recent in vivo studies from Yang and co-workers (56, 57)
showed that a ⌬N17 variant of huntingtin, which lacks the N17
module, leads to faithful reproduction of HD phenotypes in
transgenic mice. In light of these observations, and given the
relative ease of synthesis and purification of Htt-NTFs that lack
the N17 module (19), we used constructs of the form Qn-C38
for a majority of our in vitro experiments. Here, n refers to the
length of the polyQ tract. For most of the experiments, a polyQ
length of n ⫽ 40 was used for the feasibility of synthesis and
handling while still being long enough to be of a mutant or
pathological length (58). In the interest of completeness, we
also used a set of distinct Htt-NTF sequences for some of the
experiments. Fig. 1a shows a detailed inventory of all of the
sequence constructs used in one or more of our studies.
Htt-NTFs form at least three distinct phases
Previous studies (19) showed that Htt-NTFs separate into
soluble and insoluble species at bulk concentrations that are
above construct-specific saturation concentrations. Accordingly, one set of saturation concentrations can be defined in
J. Biol. Chem. (2018) 293(10) 3734 –3746
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PLLPQPQ) (Fig. 1a). In transgenic mouse models, Htt-NTFs
produce robust degeneration of the relevant neurons (35).
Although HD is characterized by Htt-NTF inclusions, the
role of these inclusions as agents of neurotoxicity has been the
topic of considerable debate (34 –44). In a recent study, Ramdzan et al. (45) showed that both soluble species and insoluble
deposits engender neurotoxicity, albeit through very different
mechanisms. Soluble forms of Htt-NTFs promote cell death via
apoptosis due to mitochondrial dysfunction. In contrast, insoluble inclusions weaken apoptosis and induce slow cell death via
necrosis by impacting cellular metabolism and promoting coaggregation and phase separation of other proteins with HttNTFs (45). In light of this recent study, it is reasonable to postulate that the entire aggregation process and the full spectrum
of Htt-NTF aggregates might have deleterious roles to play in
neurons. This postulate argues against the notion that a single
species of aggregate is toxic and suggests that attempts to target
a single toxic species are likely to be unfruitful. It may be more
advantageous to instead consider toxicity in terms of supersaturation with respect to a phase boundary (or boundaries) and
the alleviation of toxicity in terms of ligands that effectively
reduce supersaturation by shifting phase boundaries via thermodynamic linkage.
A ligand of interest that has been shown to reduce toxicity of
Htt-NTFs in multiple HD models is the ubiquitously expressed
protein profilin-1, hereafter referred to as profilin for brevity.
Profilin is a 15-kDa protein that binds to G-actin, polyP, and
phosphatidylinositol lipids through three distinct binding sites
(46 –49) and is essential for cell division and survival during
embryogenesis (50). Shao et al. (51) showed that profilin suppresses Htt-NTF aggregation through direct interactions with
Htt-NTFs. Increased expression of profilin reduces intracellular aggregation of Htt-NTFs and diminishes the toxicity of HttNTFs in cell lines, primary neurons, model organisms, and
transgenic mice (52). Therefore, a direct therapeutic approach
to HD could involve the design of ligands that mimic the effects
of profilin on Htt-NTF aggregation and alleviation of toxicity.
To realize such a therapeutic, we need a mechanistic understanding of how profilin suppresses Htt-NTF aggregation. This
is the focus of the current work.
Here, we show that Htt-NTFs form at least three distinct
phases that are preferred across distinct concentration regimes,
and we identify the concentration thresholds that demarcate
these concentration regimes. By quantifying the driving forces
for aggregation and phase separation in the presence and
absence of profilin, we show that the binding of profilin to the
proline-rich C38 region of Htt-NTFs decreases the driving
forces for aggregation and phase separation through polyphasic
linkage. Specifically, systematic measurements of profilin binding aided by coarse-grained simulations reveal that profilin
preferentially binds low-molecular weight species (monomers/
oligomers). This leads to the stabilization of monomers and
oligomers and a suppression of large-scale aggregation and
phase separation. In addition to direct interactions between
profilin and polyP, our analysis points to hitherto unknown
auxiliary interactions between profilin and the polyQ domain
that engender an enhancement in profilin binding to Htt-NTF
monomers/oligomers.

Modulation of Htt-NTF aggregation via polyphasic linkage

terms of the solubility limit, which we shall designate as cF for
fibrillar-phase saturation concentration. It is important to clarify that cF was designated as cS in the work of Crick et al. (19).
For bulk concentrations that are greater than cF, the concentration of soluble protein in the supernatant will be equal to cF,
provided that equilibrium has been established between the
soluble and insoluble phases. The value of cF is quantifiable
using previously published colorimetric assays (19). In this
approach, solutions with varying concentrations of fully disaggregated Htt-NTFs (see “Experimental procedures” and supporting Methods), were equilibrated via incubation in a temperature-controlled water bath without shaking for up to 2
weeks. The solutions were separated, via centrifugation, into
soluble supernatants that coexist with insoluble pellet fractions.
For bulk concentrations above a construct-specific threshold
value of cF, the concentration of protein remaining in solution
was found to be constant and independent of starting concentration. This is a prerequisite for the existence of a saturation
concentration (59). Values of cF for different Htt-NTF constructs with polyQ lengths of n ⫽ 40 at 37 °C are shown in Fig.
1b. The values of cF varied with Htt-NTF constructs, where
each construct either has a different sequence module that
flanks the polyQ segment or, for a given construct, the polyQ
length is different (19).
At concentrations above cF, the insoluble material in the pellet stains positively with amyloid-sensitive dyes, such as thiofla-
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vin T (ThT) (19). Transmission electron microscopy (TEM)
images confirmed that the insoluble phase is predominantly
composed of fibrillar aggregates (Fig. 1c). We also observed
coexisting small spherical aggregates in TEM images. These
observations suggest that spherical aggregates might represent
either a separate stable phase that is in equilibrium with the
fibrils and the unaggregated protein in the bulk solution, or they
are metastable phases that form as precursors to fibrils. Given
their destabilization with increased supersaturation with
respect to cF, we investigated the possibility that spherical
aggregates form as a distinct phase with saturation concentrations that are below cF. On average, the spherical species
appeared to be too small for sedimentation by centrifugation.
Therefore, we turned to right-angle static light scattering to
investigate the presence of a second phase boundary at concentrations that were subsaturated with respect to cF (i.e. for concentrations less than cF).
The average size and the concentration of scattering species
determine the intensity of scattered light in static light-scattering experiments. The appearance of a sharp discontinuity in
scattering intensity versus concentration is indicative of the
presence of a saturation concentration in a phase-separating
system (60). To test for the possible presence of a distinct saturation concentration that lies below cF, we measured right-angle static light scattering of Htt-NTF solutions as a function of
peptide concentration (Fig. 1d). We observed a discontinuity in
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Figure 1. Experimental evidence for Htt-NTF phase behavior with multiple phase boundaries. a, Htt-NTF sequence architectures used in this study. i, full
Htt exon 1, N17-Qn-C38; ii, Qn-C38; iii, C38; iv, P11; v, N17-Qn-K2; vi, Qn-K2. Here, n ⫽ 40 in all experiments except for the in-cell FRET aggregation assay (see Fig.
S1), where n ⫽ 72, and some experiments where n ⫽ 30 was compared with n ⫽ 40 (see Fig. 5e). Additionally, K2 corresponds to two lysines. b, previously
reported (19) saturation concentrations (denoted here as cF) determined by measuring the concentration of soluble protein remaining in the supernatant
(colorimetric micro-BCA assay) following quiescent incubation at 30 °C and centrifugation of the indicated Htt-NTF constructs. Consistent with the presence of
a saturation concentration, the same concentration was arrived at for a given construct regardless of the starting concentration, so long as the starting
concentration was above the saturation concentration indicated. The saturation concentration is modulated by the N17 and C38 sequence modules that flank
polyQ in Htt-NTFs. Black bars, mean ⫾ S.D. (error bars) of four independent experiments. The N17-Q40-K2 cF was below the detection limit of the assay for all
trials, so the quantity plotted is the detection limit and represents an upper bound for the N17-Q40-K2 cF. Statistical significance was determined by one-way
ANOVA with Tukey’s range test for post hoc analysis. ***, p ⬍ 0.001. ‡, the N17-Q40-K2 cF data were not included in the statistical significance analysis for the
reason cited above. c, TEM image of Q40-C38 fibrils observed at a concentration supersaturated with respect to cF (14 M). Two of the fibrils in the image are
indicated with white arrows labeled F, and two examples of spherical aggregates are indicated with white arrows labeled S. See Fig. 4c for an additional example
of fibrils and spheres. d, right-angle static light scattering of Q40-C38 in 20 mM Tris, 5 mM EDTA, 1 mM DTT, pH 7.4, as a function of Q40-C38 concentration.
The discontinuity at ⬃290 nM is indicative of a phase boundary. e, TEM image of Q40-C38 monomers and small oligomers observed at a concentration
subsaturated with respect to cS (126 nM). This particular field of view contains monomers/small oligomers, two of which are indicated with white arrows. f, TEM
image of Q40-C38 spherical aggregates observed at a concentration supersaturated with respect to cS but subsaturated with respect to cF (295 nM). One of the
spherical aggregates is indicated with a white arrow labeled S. All TEM images (c, e, and f) are at the same scale. Scale bar, 100 nm.

Modulation of Htt-NTF aggregation via polyphasic linkage
“aggregates” for molecules engaged in intermolecular interactions that can range from dimers to fibrils, whereas “oligomers”
refers to aggregates smaller than the spherical aggregates that
characterize the S phase.
Profilin preferentially binds M-phase species

the concentration dependence of the light-scattering intensity
at ⬃290 nM for Q40-C38. This is consistent with the presence of
a phase boundary or saturation concentration, which we term
cS for spherical-phase saturation concentration. TEM images
indicate that species considerably smaller than the 10 –20-nm
size, which presumably include monomers and oligomers, are
the predominant morphological species at concentrations
below cS (Fig. 1e). Conversely, spherical aggregates with a diameter of ⬃25 nm are the preferred morphologies for concentrations between cS and cF (Fig. 1f). We analyzed multiple independent TEM images to quantify the distribution of aggregate
sizes. This analysis confirmed that a single size distribution was
present at concentrations below cS, whereas two distinct size
distributions were present at concentrations that lie between cS
and cF (Fig. S2).
Our results, derived from a joint analysis of solubility, light
scattering, and morphological measurements, lead to a phase
diagram that delineates the presence of at least three distinct
phases separated by two phase boundaries (Fig. 2a). For total
concentrations ct that are lower than cS, Htt-NTFs populate
monomers and oligomers (M phase). For concentrations
between cS and cF, the concentration of monomers/oligomers
saturates, and these species are in equilibrium with large spherical aggregates (S phase). Soluble, spherical aggregates that are
⬃25 nm in diameter are the predominant morphologies in the
S phase. For ct ⬎ cF, the concentration of soluble species saturates, and equilibrium is established between soluble species
and insoluble, large, ␤-sheet–rich fibrils with a bottlebrush
architecture that constitute the F phase (61). We use the term
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Figure 2. Schematic representation of Htt-NTF phase behavior and polyphasic linkage. a, Htt-NTF phase behavior is described by three phases (M, S,
and F phase), color-coded as red, blue, and green, respectively, and two phase
boundaries (cS and cF) indicated by gray lines between the phases. The total
monomer-equivalent Htt-NTF concentration (horizontal axis) with respect to
these boundaries will determine whether monomers and oligomers, spherical aggregates, or fibrils form. b, the influence of a binding partner (profilin)
on the Htt-NTF cS phase boundary. The phase boundary is depicted as a solid
gray line in the absence of profilin (i) and for three different profilin binding
scenarios (ii–iv). The relative number of profilin (black circles) associated with
each phase (M or S) indicates which phase is preferentially bound. The dotted
gray line in ii and iii indicates the cS in the absence of profilin, and the red and
blue arrows indicate the direction of the shift in the cS if the M or S phase is
preferentially bound, respectively. In scenario iv, profilin binds both phases
equally well, and thus no shift in cS is observed. The orientation of b is rotated
90° with respect to a for formatting purposes. See “Results” for further
description of polyphasic linkage.

The quantitative phase diagrams for Htt-NTFs become useful when considering the impact of binding partners on phase
behavior. Polyphasic linkage provides a framework for understanding how ligand binding modulates the phase equilibria of
molecules that undergo aggregation and phase separation (30,
31) (Fig. 2b). Polyphasic linkage can be explained by considering the simple example of a macromolecular solution that separates into two distinct phases labeled as A and B, respectively.
Here, A could be the dilute phase and B the dense phase. In the
absence of ligand, we denote cA as the saturation concentration
of the macromolecule in the A phase. The establishment of
phase equilibrium in the presence of ligand, which refers to the
equalization of chemical potentials of the macromolecule
across the two phases, leads to the following scenarios. Assuming the ligand binds to the macromolecule in both phases, then
the saturation concentration for phase separation of the macromolecule in the presence of the ligand becomes cA(L) ⫽
cA(pA/pB) (30, 31). Here, pA and pB are the binding polynomials
for the binding of ligand to species in the A and B phases,
respectively. For reversible macromolecular associations, a
binding polynomial quantifies the sum of the activities (concentrations) of all bound and unbound species involving the
macromolecule relative to the activity (concentration) of the
unbound macromolecule (62). The negative logarithm of
the binding polynomial is proportional to the free energy of
binding. Accordingly, if pA is greater than pB, then species in the
A phase will have higher affinity for the ligand when compared
with species in the B phase. In this scenario, ligand binding will
help retain a higher concentration of the macromolecule in the
A phase, and hence cA(L) will be greater than cA. The converse is
true if pA is less than pB, which would engender increased partitioning of the ligated macromolecule into the dense phase, B.
Finally, ligand binding will not impact the phase equilibrium if
pA ⫽ pB.
To understand the basic tenets of polyphasic linkage, we consider the impact that profilin binding has on the phase boundary between the M and S phases. In accordance with polyphasic
linkage, if profilin were to bind preferentially to the M phase of
Htt-NTFs, then the value of cS would shift to higher concentrations (Fig. 2b, ii). In contrast, preferential binding to the S phase
would shift cS to lower concentrations (Fig. 2b, iii). Equivalent
binding to species in the two phases would have no effect on the
phase boundary (Fig. 2b, iv). These scenarios are depicted qualitatively in Fig. 2b.
Given knowledge of the phase diagram for Htt-NTFs, we
hypothesized that profilin must reduce aggregation/phase separation through a polyphasic linkage mechanism, whereby it
binds preferentially to M-phase species to destabilize the S and
F phases. This hypothesis is directly testable by measuring saturation concentrations in the absence (e.g. Fig. 1d) and presence of profilin. A lack of change in the saturation concentration in the presence of profilin may indicate no binding or

Modulation of Htt-NTF aggregation via polyphasic linkage

equivalent binding to the two phases. Alternatively, if the saturation concentration changes in the presence of profilin, then
the direction of the change will point to the phase that is stabilized or destabilized by ligand binding.
We performed static right-angle light scattering measurements as a function of Q40-C38 concentration in the presence
of fixed concentrations of profilin (Fig. 3a). The discontinuity in
the concentration-dependent scattering profile, which quantifies the cS of Q40-C38, increases by more than an order of magnitude in the presence of profilin. The inferred value of cS
increases from ⬃290 nM in the absence of profilin to ⬃3 M in
the presence of 1 M profilin (Fig. 3b and Table S1). The value of
cS increases with increasing profilin concentration and appears
to plateau to a value of ⬃6 M in the presence of 20 M profilin.
The increase of cS in the presence of profilin suggests that binding to profilin destabilizes the S phase. Our reasoning, based on
thermodynamic linkage relations, suggests that profilin must
bind preferentially to either the M or F phases, whereby ligandinduced changes to one phase boundary in a closed system will
necessarily lead to changes in all phase boundaries.
To infer the impact of profilin binding on the stability of the
F phase, we quantified the impact of the presence of profilin on
the kinetics of fibril formation and the morphologies of fibrils
that are formed in the presence of profilin. We monitored the
kinetics of fibril formation by following the rate of change of
ThT fluorescence. In these measurements, we fixed the total
concentration (ct) of Q40-C38 to be above its intrinsic cF such
that the degree of supersaturation with respect to cF, quantified
as ln(ct/cF), was 0.75. A series of independent measurements
were performed, each in the presence of a different concentration of profilin (Fig. 4a). As the profilin concentration
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Figure 4. The influence of profilin on Q40-C38 fibril formation. a, ThT assay
of Q40-C38 aggregation kinetics at a fixed concentration of Q40-C38 in the
presence of various concentrations of profilin. ThT fluoresces upon binding to
amyloid-like fibrils, thus providing a readout of fibril formation in the form of
fluorescence intensity. b, the plateau ThT fluorescence intensity (ThT Imax) and
the time to reach 50% Imax (t50) (red and blue, respectively), are plotted as a
function of profilin concentration. c, representative TEM image of a sample
taken from an aggregation assay in the absence of profilin showing an abundance of long fibrils coexisting with spherical aggregates. d, representative
TEM image of a sample taken from an aggregation assay in the presence of 5
M profilin shows short fibrils few in number as well as spherical aggregates
and oligomers or possibly monomers. His-tagged profilin was marked on the
carbon-coated copper grid with 5-nm nickel-nitrilotriacetic acid-gold nanoparticles, which appear as black dots. Examples of gold nanoparticles are indicated with black arrows. Examples of fibrils and spheres are indicated with
white arrows labeled F and S, respectively, in c and d.

increased, fewer fibrillar aggregates formed, as indicated by the
maximum ThT intensity reached, and the rate of fibril formation was slowed, as indicated by the time required to reach
half-maximum intensity (Fig. 4b). These results are consistent
with ligand binding shifting the intrinsic cF of Q40-C38 to
higher values. Negative stain TEM images of samples from the
end point of aggregation assays confirms that in the presence of
profilin, fibrils appear to be reduced in both length and number
(Fig. 4, c and d).
To determine whether profilin was bound to fibrils or other
aggregates, we tagged profilin on TEM sample grids with 5-nm
gold nanoparticles functionalized with a nickel moiety that
binds histidine tags. Imidazole buffer washes were used to prevent nonspecific binding. The gold nanoparticles were found
predominantly near oligomers and less frequently near larger
spherical aggregates or fibrils (Fig. 4d). In total, 257 gold nanoparticles in three TEM images were counted and classified
according to their association with M-, S-, or F-phase species.
Of the 257 gold nanoparticles, 133 (51.7%) were associated with
M-phase species, whereas only 49 (19.1%) were associated with
S-phase species, and 75 (29.2%) were associated with F-phase
species (see supporting Methods for details). Taken together,
the results from Figs. 3 and 4 suggest that profilin binding destabilizes the S and F phases in favor of the M phase via polyphasic
linkage. This is attributable to the preferential binding of profilin to species of the M phase. In light of this suggestion, we
investigated the mode of binding of profilin to species of the M
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Figure 3. Profilin shifts the cS of Q40-C38 through polyphasic linkage. a,
right-angle static light scattering of Q40-C38 solution as a function of Q40-C38
concentration, in the absence of profilin (black, reproduced from Fig. 1d) and
in the presence of 1, 5, 10, or 20 M profilin (blue, purple, red, and green,
respectively) in 20 mM Tris, 5 mM EDTA, 1 mM DTT, pH 7.4. One representative
trial at each profilin concentration is shown, and the plots are arbitrarily offset
in the vertical direction for the sake of clarity. The values of cS for Q40-C38 in
the presence of each of these concentrations of profilin are indicated by the
discontinuity in slope, and each discontinuity is marked using an open circle.
We note that the slope of the low-concentration arm of the 10 M profilin data
set differs from the other data sets and suspect that this is the result of an
experimental artifact (see “Experimental procedures”). Regardless, there was
good agreement between trials concerning the location of the discontinuity,
as is evident in b. b, Q40-C38 cS measured in a plotted as a function of the
profilin concentration. The intersections of “best-fit” lines from jackknife sampling for at least three trials at each profilin concentration are plotted (see
supporting Methods). Black bars, mean ⫾ S.D. (error bars). Statistical significance was determined by Welch’s ANOVA with Games–Howell post hoc analysis. **, p ⬍ 0.01; ***, p ⬍ 0.001. Colors are the same as in a. Even the lowest
concentration of profilin tested (1 M) resulted in more than an order of magnitude increase in the cS of Q40-C38.

Modulation of Htt-NTF aggregation via polyphasic linkage

phase to uncover a mechanistic understanding of how the
M-phase species are stabilized by profilin binding.
Profilin binds to polyP and binding to Htt-NTFs is aided by the
presence of the polyQ region
Profilin binds to polyP through a distinct binding site (47–
49, 63, 64). The C38 region of Htt-NTFs encompasses two
polyP modules (P11 and P10) connected by a 17-residue linker
(L17) that is rich in Pro, Gln, and Leu residues. As described
above, pulldowns performed by Shao et al. (51) indicated that
the polyP binding pocket of profilin is responsible for binding
Htt-NTFs, and our follow-up experiments confirmed that the
Htt-NTF C38 stretch is essential to elicit profilin-dependent
reduction in aggregation (Fig. S1). Thus, the main mode of
interaction between profilin and Htt-NTFs is through direct
binding to polyP modules in the C38 region.
To place the interactions of profilin with Htt-NTFs on a
quantitative footing, we first measured the binding affinity of
profilin to polyP in isolation and in the context of C38 (Fig.
S3a). We used a fluorescence-based binding assay developed by
the Pollard laboratory (49). The binding of polyP ligands to
profilin leads to increased fluorescence of Trp-3 and Trp-31
from profilin and a blue shift in the maximal wavelength for Trp
fluorescence. We used the fluorescence intensity at 320 nm to
quantify the binding of profilin to C38 and compared this with
the binding of profilin to an 11-mer of polyP (P11). The binding
data for P11 and C38 were fit to a model with a single binding
site (Fig. S3a). Here, profilin is the macromolecule, and P11 and
C38 are the ligands. The dissociation constant Kd,P11 that we

obtain for the binding of P11 to profilin (106.5 M) matches
published estimates (49, 65).
In contrast to P11, C38 is a bivalent ligand with two polyP
modules. The dissociation constant Kd,C38 for the binding of
profilin to C38 is 50.7 M, which is essentially half the value of
Kd,P11. When we used the number of polyP tracts to normalize
the binding isotherms, the isotherms overlay, indicating that
the difference in dissociation constants results from C38 having
two binding sites for profilin (Fig. S3b). The fact that Kd,P11 ⬇
2Kd,C38 suggests that profilin binds to the two sites on C38
independently. This was confirmed using Hill and Scatchard
analyses as shown in Fig. S4. We obtained an average value of
1.0 as our estimate for the Hill coefficient, which quantifies the
size of the cooperative unit for binding. Therefore, we conclude
that profilin molecules bind independently to the individual
polyP modules in C38. Accordingly, the lowering of Kd,C38
derives exclusively from doubling the concentration of polyP by
doubling the polyP valency in C38. Additionally, in three separate sets of fluorescence experiments, we fixed the concentration of profilin and titrated the concentrations of N17, polyQ
(Q30), and L17. We were unable to detect any measurable
changes in Trp fluorescence of profilin for a range of concentrations of each of N17, polyQ, and L17 as ligands. We conclude
that these modules have undetectably weak interactions with
profilin at or near the polyP-binding site, although interactions
with other distal sites cannot be ruled out.
Next, we measured the binding of profilin to Q40-C38, a construct possessing both a polyQ and C38 tract. The binding data
were fit to a 1:1 binding model, and the inferred apparent disJ. Biol. Chem. (2018) 293(10) 3734 –3746

3739

Downloaded from http://www.jbc.org/ at Washington University on March 14, 2018

Figure 5. The effect of polyQ on profilin binding to Htt-NTFs. a, binding isotherms of 5 M profilin with C38 (black) versus 5 M profilin with Q40-C38 (purple).
The presence of the polyQ tract enhances binding at a given profilin concentration. b, binding isotherms of 1, 5, 10, and 20 M profilin with Q40-C38. c, apparent
Kd values extracted from fits to the isotherms in a. A slight dependence of the Kd,app on profilin concentration is apparent, although a one-way ANOVA test of
the data revealed that the difference is at the threshold of significance, with a p value of 0.0507. d, when the concentration of each binding isotherm is adjusted
by the magnitude of the profilin-dependent shift in cS (cS,Pfn/cS,intrinsic), then the binding isotherms collapse to a single curve, confirming that the observed
dependence of Kd,app on the profilin concentration is due to profilin-dependent changes in partitioning of Q40-C38 molecules between the M- and S-phases
(see “Results” for details). e, comparison of apparent Kd values of C38 (black) and Q40-C38 (purple) with Q30-C38 (orange) and N17-Q30-C38 (teal), all measured
at 5 M profilin. Statistical significance was determined by one-way ANOVA with Tukey’s range test for post hoc analysis. ***, p ⬍ 0.001. Binding of profilin
appears to correlate with aggregation propensity, which is dictated by polyQ length (Q30 versus Q40) and flanking sequence context (absence or presence of
N17). Black bars in c and e indicate the mean ⫾ S.D. (error bars) of three or four independent experiments.
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or N17-polyQ. However, the evidence for cooperativity in binding does not illuminate the specific mechanism through which
profilin binding is enhanced in the presence of polyQ and N17.
To explore possible origins for this behavior, we used coarsegrained simulations to explicitly test distinct models.
Modeling suggests that profilin modulates Htt-NTF phase
behavior through a combination of specific interactions with
polyP and auxiliary interactions with polyQ
To understand the source of the enhanced profilin binding in
constructs with flanking N-terminal polyQ regions, we turned
to coarse-grained simulations to identify the most plausible
mechanistic models for our observations. Our modeling probes
how the apparent binding affinity is influenced by increased
local concentration and auxiliary interactions that involve
regions on profilin that do not overlap with its polyP-binding
site. Here, increased local concentration refers to the clustering
of polyP segments due to Q40-C38 oligomerization. Auxiliary
interactions can also contribute to the apparent increase in
binding affinity through multivalency of both Q40-C38 oligomers and profilin (70 –72).
Using a phenomenological coarse-grained model, in which
we represent profilin and Q40-C38 as multiple spheres or
“beads” connected by “springs” that mimic their atomistic
architectures, we performed simulations in which binding was
quantified between profilin and C38 or Q40-C38 as a function of
Q40-C38 oligomer size. The general architecture of the coarsegrained model is shown in Fig. 6a. Each profilin molecule has a
polyP-binding site that can interact with a polyP segment in
either C38 or Q40-C38. We refer to this interaction as the primary interaction between profilin and C38 or Q40-C38, given
that this is the interaction that is measured in the fluorescence
experiments. If an increased local concentration of polyP segments leads to the observed experimental results, then the
inclusion of this primary interaction between profilin and C38
or Q40-C38 should be sufficient to reproduce trends in binding
that are consistent with the experimental results. In this scenario, Q40-C38 oligomerization should increase the local concentration of C38 modules. To be consistent with experimentally measured data, the simulation results would need to
reproduce two key findings: 1) binding to C38 alone should be
weaker than binding to Q40-C38 (Fig. 5a), and 2) binding to
M-phase oligomers should be stronger than binding to S-phase
aggregates (Fig. 3). Our results show that a model restricted to
inclusion of primary interactions alone will not reproduce
either of the experimental observations listed above. Instead, in
a model that only accounts for primary interactions, we found
that binding to C38 alone was stronger than binding to Q40C38, and the fraction of profilin molecules bound decreased
from that of the Q40-C38 monomer with increasing Q40-C38
oligomer size (Fig. 6c). This decrease originates from stericeffects, whereby bound profilin molecules, as well as other C38
stretches, get in the way of unbound profilin, occluding the
C38-binding sites and reducing the effective concentration of
free C38. This result suggests that an increased local concentration of polyP segments alone cannot account for the experimentally observed trends.
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sociation constant (Kd,app) in the presence of 5 M profilin was
found to be 8.8 M for Q40-C38 (Fig. 5a). This value for Kd,app is
⬃6-fold lower than the intrinsic value of Kd,C38 ⫽ 50.7 M for
C38. We also measured the binding of Q40-C38 to profilin at
several different fixed concentrations of profilin. These measurements yield a modest decrease in the inferred Kd,app as profilin concentration increases (Fig. 5 (b and c) and Table S1) and
suggest one of two possibilities; either profilin undergoes a
concentration-dependent change, such as dimerization, that
influences its binding to Q40-C38, or alternatively, the effect
can be explained in terms of a shift in the concentration of
Q40-C38 within the M phase that is caused by profilin binding
leading to a modulation of the phase boundary. Rennella et al.
(66) have shown that profilin only forms sparsely populated
oligomers at millimolar concentrations. In our studies, we
never exceeded 20 M profilin. Therefore, it appears safe to
conclude that profilin oligomerization is not relevant.
We know now that profilin binding increases the value of cS.
Because the cS dictates the relative amounts of molecules in the
M and S phases, which in turn influences Kd,app, the observed
dependence of Kd,app on the profilin concentration could be
due to changes in the partitioning of Q40-C38 molecules
between the M and S phases resulting from profilin-dependent
changes in the cS. In support of this hypothesis, we find that
adjusting the concentration of each binding isotherm by the
magnitude of the profilin-dependent shift in cS (defined here as
cS,Pfn/cS,intrinsic, where cS,Pfn is the cS measured in the presence
of a given concentration of profilin, and cS,intrinsic is the cS measured in the absence of profilin (see Fig. 3)), leads to binding
isotherms that collapse onto a single master curve (Fig. 5d).
Therefore, lowering of Kd,app at higher profilin concentrations
is thermodynamically linked to the profilin-dependent increase
in cS, which increases the M-phase concentration of Q40-C38
molecules.
Our measurements also show that the binding of profilin to
Htt-NTF constructs depends on the length of the polyQ segment and the presence of the N17 module (Fig. 5e and Table
S1). Specifically, the value of Kd,app, measured in the presence of
a fixed profilin concentration, is lowered upon increasing the
polyQ length in Qn-C38 constructs. The value of Kd,app is further lowered upon the addition of the N17 module, which is
shown by comparing the values for Kd,app obtained for N17Q30-C38 with those obtained for Q30-C38 and Q40-C38. The
decrease in Kd,app in going from Q30-C38 to N17-Q30-C38 is
equivalent to the decrease we observe in going from Q30-C38
to Q40-C38. Given that increasing the polyQ length and the
presence of N17 both promote Htt-NTF oligomerization/aggregation (19, 68, 69), these results are consistent with
the idea that the binding of profilin to Htt-NTFs is enhanced
due to polyQ- and N17-dependent assembly. These results further suggest that oligomerization can engender positive cooperativity in binding, which results in a reduced Kd,app. Consistent with this interpretation, Scatchard analysis of profilin
binding to Q40-C38 indicated positive cooperativity, which was
absent in the binding of C38 to profilin (Fig. S4). Additionally,
binding of profilin to Q30-C38 and N17-Q30-C38 also exhibited
positive cooperativity (Fig. S5), offering a clear correlation
between the observed cooperativity and the presence of polyQ
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Next, we tested three distinct models for auxiliary interactions that engender multivalency and might explain the
observed experimental results. The distinct auxiliary interactions are denoted as polyQ-Pfn interactions, linker-Pfn interactions, and Pfn-Pfn interactions. Here, Pfn refers to profilin. In
each of these models, the coarse-grained profilin molecule can
engage in an auxiliary interaction, in addition to the primary
polyP interaction. In the polyQ-Pfn interaction model, the auxiliary interaction is between the polyQ bead of a Q40-C38 molecule and a nonspecific region on the profilin molecule that is
distinct from the polyP-binding site (Fig. 6b). This model
accounts for experimental results, which suggest that long
polyQ tracts and polyQ aggregates can interact nonspecifically
with other molecules, given the uniformly “sticky” surface of
the polyQ domain (73–76). This model allows for the possibility
of a heterotypic multivalent complex in which a single profilin
molecule is engaged in two different types of interactions with a

Discussion
We showed that aggregation and phase separation of HttNTF constructs is characterized by at least three distinct
phases. We also showed that the values of cS shift to higher
concentrations, and fibril formation is destabilized in the presence of profilin. This implies that profilin binds preferentially to
M-phase species of Htt-NTFs. In most situations that involve
binding between a protein and a heterogeneous mixture of oligomers or aggregates, it would be impossible to determine which
species in the heterogeneous mixture is/are preferentially
bound. However, with a quantitative description of the phase
boundaries that govern the distribution of species, we can apply
the concepts of polyphasic linkage to identify the phases that
are preferentially bound. This is important because if one or
more types of aggregate species are toxic to cells, it is essential
that one knows which phase is preferentially bound by a ligand
or small molecule to understand its effect on the equilibrium
and therefore toxicity. This is essential, given that preferential
binding to any one species will influence the equilibrium populations of all aggregate species.
We complemented experiments that probe the impact of
profilin binding on phase boundaries with measurements of
binding isotherms. Our results from experiments and modeling
suggest that increasing the local concentration of C38 domains
through polyQ-dependent oligomerization cannot explain the
results of the binding experiments. Instead, the experimental
results are consistent with a model that invokes a combination
of primary interactions between polyP and profilin and weak,
auxiliary interactions between the polyQ domain and profilin.
J. Biol. Chem. (2018) 293(10) 3734 –3746
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Figure 6. Coarse-grained model identifies an auxiliary interaction necessary for the experimentally observed profilin effect. a, visual representation of the architecture used for the increased local concentration model.
Q40-C38 and profilin are represented by a set of spheres or “beads” as defined
in the top legend (see supporting Methods for model details). The primary
interaction between profilin (Pfn) and the polyP segment of C38 is denoted
by a green arrow. b, visual representation of the architecture used for the
polyQ-Pfn auxiliary interaction model. This model is identical to the increased
local concentration model, except an auxiliary interaction is added between
the polyQ bead and a nonspecific region of the profilin molecule that does
not overlap with the polyP interaction site (red arrow). c and d, fraction of
profilin molecules bound to polyP segments observed in coarse-grained simulations of the increased local concentration model and the polyQ-Pfn auxiliary interaction model, respectively. Each simulation contained 210 Pfn molecules and 630 C38 stretches. Additionally, each simulation had a homogeneous
distribution of cluster sizes, X (X ⫽ 1, 3, 6, 9, 15, 35, 70, 210), such that the number
of clusters multiplied by X equaled 630. Each bar denotes results from simulations
performed with a distinct cluster size as indicated by the bottom legend. A cluster
size of zero denotes C38 without the polyQ domain. Gray beads in the legend
denote beads that interact with profilin via the primary Pfn-PolyP interaction.
Error bars, S.E. from five independent simulations.

Q40-C38 oligomer. In the linker-Pfn interaction model, the
auxiliary interaction is between the non-proline residues of L17
and the face opposing the polyP-binding site on profilin, which
is enriched in polar residues (Fig. S6b) (64). This model queries
the possibility of a heterotypic complex in which a single profilin molecule interacts with the glutamine and leucine residues
of L17 from one Q40-C38 molecule and a polyP region from
another Q40-C38 molecule. Finally, in the Pfn-Pfn interaction
model, the auxiliary interaction is a stable dimerization of two
profilin molecules (Fig. S6c). This model is intended to address
published conjectures suggesting that profilin can undergo
dimerization (66, 77) and allows for the possibility of a homotypic complex in which a profilin dimer engages in interactions
with two distinct polyP sites.
Fig. 6d and Fig. S6 (d–f) show the results obtained from simulations based on each of the three auxiliary interaction models.
Only the polyQ-Pfn interaction model (Fig. S7) was able to
reproduce both experimental findings. Specifically, our calculations based on this model show that binding to C38 alone was
weaker than binding to Q40-C38, and binding to small oligomers was stronger than binding to large aggregates (Fig. 6d and
Fig. S6d). Neither the linker-Pfn interaction model nor the PfnPfn interaction model was able to reproduce both experimental
results (Fig. S6, e and f). Taken together, the results from coarsegrained modeling suggest that an auxiliary interaction between
profilin and the polyQ domain within Htt-NTFs probably plays
an important role in modulating Q40-C38 phase behavior.

Modulation of Htt-NTF aggregation via polyphasic linkage

Understanding the effects of Htt-NTF binding partners in terms
of polyphasic linkage
Htt-NTFs engage in a wide variety of protein-protein interactions (75, 81–90). These “interactomes” are tissue-specific,
and within a tissue type, the nodes and edges in an interaction
network are known to be different for Htt-NTFs with wildtype
versus mutant polyQ lengths (90). The polyphasic linkage formalism of Wyman and Gill (30, 31) provides a route for modeling the phase behavior of Htt-NTFs and quantifying the
impact of protein-protein interaction nodes on this phase
behavior.
From a phenotypic standpoint, gain-of-function toxicity
resulting from the accumulation of S- and F-phase species
appears to be weakened by interactions with profilin (91). It is
also conceivable that other heterotypic interactions with HttNTFs modulate phase boundaries in very different ways. For
example, preferential binding to S-phase species will, via linkage effects, lead to a lowering of cS and a widening of the gap
between cS and cF. Conversely, preferential binding to
F-phase fibrils will lower cF, destabilize the M and S phases,
and promote the formation of long, stable fibrils. Indeed,
there appear to be proteins in interactomes that preferentially interact with high-molecular weight S- and F-phase species. For example, SH3GL3, a protein involved in endocytosis,
binds the linker region of C38 and has been shown to bind
preferentially to mutant Htt-NTF and accelerate mutant HttNTF aggregation (92, 93). Recent studies showed that SH3GL3
binds monomeric wildtype and mutant Htt-NTF similarly (92).
However, upon introduction of aggregated mutant Htt-NTF,
retention of mutant Htt-NTF on SH3GL3 pull-downs was
increased in a manner that correlated with increased aggregation of mutant Htt-NTF. Together, these results suggest that
the binding of SH3GL3 increases the stability of the F phase of
mutant as opposed to wildtype Htt-NTFs due to the increased
aggregation propensity of mutant Htt-NTFs. This points to
preferential binding of SH3GL3 to larger fibrillar aggregates.
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This should shift cF to lower values. Our suggestion is consistent with findings of increased fibril formation when SH3GL3 is
co-expressed with Htt-NTFs in cellular models (93).
Profilin is one of the most abundant cellular proteins, with a
copy number of around 107/cell (94). We speculate that the
high natural abundance coupled to its intrinsic ability to bind
polyP tracts leads to the serendipitous consequence of being
able to influence cellular aggregation and phase separation of
Htt-NTFs. This raises the possibility that there may be other
naturally occurring proteins that show even greater potency
but are not readily identified in cellular screens due to their low
cellular concentrations. Indeed, given the wide prevalence of
polyP-binding modules, such as WW, SH3, and EVH1 domains
(95), a plausible approach would be to identify other, potentially
more powerful modifiers of intracellular aggregation and phase
separation. This could be achieved by driving overexpression of
putative modifiers based on the combined criteria of polyPbinding domains and low molecular weight. Similarly, profilin
itself may represent a useful scaffold upon which protein engineering (96) could be used to tune its specificity and affinity for
Htt-NTFs. Regardless of the “physiological relevance” of interactions between profilin and Htt-NTFs, it is clear that profilin is
capable of reducing Htt-NTF aggregation and toxicity, and
therefore it serves as a useful model for the design of therapeutics for Huntington’s disease. The same logic applies to any
protein or molecule shown to bind a pathologically aggregating
protein and reduce its toxicity, irrespective of the “physiological
relevance” of that interaction.

Experimental procedures
Synthesis of peptide constructs
Peptides were purchased from Watsonbio Sciences (Houston, TX) in crude form and stored at ⫺20 °C until use.
Peptide purification
Crude peptides were disaggregated in undiluted formic acid,
diluted to 30% formic acid with deionized water, and purified
using reverse-phase HPLC on a semipreparative 300SB-C3
reverse-phase column (Agilent, Santa Clara, CA). Elution fractions containing pure peptide were pooled, lyophilized, and
stored at ⫺20 °C until use.
Peptide disaggregation
Peptides were disaggregated using the method reported
previously (19). Further details are given in the supporting
Methods.
Recombinant expression and purification of profilin
The genetic sequence of human profilin-1 (hereafter referred
to as profilin) in the pRK174 vector, which includes a T7 promoter, a His6 tag, and an ampicillin resistance gene, was verified
by DNA sequencing (GENEWIZ, South Plainfield, NJ). The
pRK174-His6-profilin plasmid was transformed into Escherichia coli BL21 (DE3) cells. Cells were grown at 37 °C in Luria
broth with 100 g/ml ampicillin to an A600 of ⬃0.8 with shaking
at 220 rpm. Protein expression was induced by the addition of
1.0 mM isopropyl 1-thio-␤-D-galactopyranoside and harvested
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Previous studies have shown that increases in apparent affinity can result from a combination of specific and nonspecific
interactions and that the magnitude of the increase depends on
the size of the nonspecific interaction surface (78). This result is
consistent with the decreasing Kd,app between Qn-C38 and profilin observed as the length of the polyQ domain was increased.
Based on our coarse-grained simulations, we propose that these
auxiliary interactions will involve sites on the surface of profilin
that are non-overlapping with the polyP-binding site.
Given that overexpression of profilin in cellular models
reduces Htt-NTF dependent toxicity (51) and that multivalency
appears to be important for the relevant interactions needed
between profilin and Htt-NTFs, it appears that exploiting multivalent interactions might be an important strategy for designing therapeutics targeting Htt-NTFs. Such strategies have been
developed for the design of antimicrobial peptides as a means to
treat bacterial infections (79) and for selective targeting of different amyloid-␤ species as a means to alleviate neurotoxicity
(80). Our results suggest that the design of multivalent peptides
can increase binding affinity, thus allowing these peptides to
compete more effectively with other ligands in the cell.

Modulation of Htt-NTF aggregation via polyphasic linkage

Steady-state tryptophan fluorescence
Steady-state fluorescence emission spectra of profilin were
measured using a PTI QuantaMaster fluorometer (Horiba Scientific, Edison, NJ). Disaggregated peptide was reconstituted in
Tris buffer as described, and profilin was added from a concentrated stock solution. Profilin was maintained at a constant
concentration while the concentration of the Htt-NTF construct was titrated by dilution using a profilin solution that was
identical to the Htt-NTF ⫹ profilin solution, except that it contained no Htt-NTF peptide. This solution was then used for
stepwise dilution of the Htt-NTF ⫹ profilin solution. All experiments were repeated at least three times. The reverse titration
was also performed (by adding concentrated Htt-NTF stock to
increase the total sample concentration) with C38 and profilin,
and the same result was obtained regardless of the direction of
the titration. Binding experiments were carried out in a 3 ⫻
3-mm fluorometer cell (Starna, Atascadero, CA) at 22 °C. Emission spectra were recorded from 310 to 380 nm, with excitation
at 295 nm (5-nm slit width). All spectra were corrected for the
contribution of buffer. Fluorescence emission intensities at 320
nm were recorded as a function of Htt-NTF concentration.
Binding isotherms were fit using nonlinear least-squares analysis as described in the supporting Methods.

sample). Even minute contaminants can introduce noise or
otherwise obscure the signal of interest, and it was not always
possible to completely exclude minor contaminants from the
sample. Because of this, none of the trials carried out were completely devoid of artifact. However, despite these challenges,
our method yielded good agreement across trials with regard to
the location of the discontinuity. In contrast, a physical interpretation of the slope on either side of a discontinuity was not
pursued further because of sensitivity to the potential artifacts
discussed above. The method of determining optimal linear fits
is given in the supporting Methods.
Negative-stain TEM
Samples were either recovered from fluorescence and light
scattering experiments or freshly prepared in the same manner
(i.e. samples were disaggregated using the TFA/HFIP method,
reconstituted in buffer, and then diluted to various concentrations). Sample solutions were briefly vortexed, and 10 l of each
sample was applied to a parafilm strip. Carbon-coated copper
grids (Ted Pella, catalog no. 01843, 300-mesh) were inverted on
the sample droplets for 15–20 s. The grids were then washed by
inverting them on 50-l droplets of deionized water for about
5 s, after which the water was wicked away with Whatman filter
paper. Finally, the grids were inverted on droplets of 0.5% uranyl acetate for 1 min, wicked dry with Whatman filter paper,
and air-dried overnight. For samples in the presence of (Histagged) profilin, the location of profilin was marked on the EM
grid with 5-nm nickel-nitrilotriacetic acid-gold nanoparticles.
Unbound profilin was rinsed away with buffer before applying
the gold nanoparticle solution, and unbound or nonspecifically
bound gold nanoparticles were washed away with imidazole
buffer before imaging. TEM images were collected on an FEI
Tecnai G2 Spirit transmission electron microscope operating
at 120 kV and equipped with a Gatan digital camera. All images
are representative of multiple distinct locations on the EM grid.
Sedimentation assay
Peptides were disaggregated using the TFA/HFIP method
described in the supporting Methods and aliquoted (1.5 ml)
into 1.6-ml Eppendorf tubes, which were then capped and
sealed with Parafilm. The samples were incubated in a water
bath at the specified temperature for 2 weeks. After 2 weeks of
incubation, the samples were centrifuged for 100 min at
25,000 ⫻ g. Two aliquots of the supernatant were removed, and
the peptide concentrations were determined using the microBCA (bicinchoninic acid) assay (97) (Pierce).

Right-angle static light scattering

Thioflavin T fluorescence measurements

The intensity of static right-angle light scattering at 350 nm
(I) was measured at each titration point immediately before
each fluorescence measurement using the same instrument.
The intersection of linear fits to I versus [Q40-C38] (log-log
plot) identified discontinuity points in the concentration dependence of the scattering intensity, which is indicative of a phase
transition. Due to the sensitive nature of the measurement, it
was somewhat prone to experimental artifact (such as persistent aggregates resulting from incomplete peptide disaggregation or the introduction of dust or other foreign material to the

ThT assays were performed as described by Crick et al. (19).
Further details are given in the supporting Methods.
Statistical significance tests
Data sets were first subjected to either Bartlett’s or Levene’s
test for equal variance. Data sets exhibiting equal variance were
subjected to a one-way ANOVA with Tukey’s range test for
post hoc analysis. Data sets that did not pass the equal variance
test were subjected to Welch’s ANOVA with Games–Howell
post hoc analysis. Significance levels are indicated with one,
J. Biol. Chem. (2018) 293(10) 3734 –3746
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by centrifugation at 4,500 rpm for 30 min at 4 °C, ⬃4 h after
induction. The resulting cell pellets were resuspended in nickel
column buffer (20 mM sodium phosphate, 500 mM NaCl, 30 mM
imidazole, pH 7.5). Protease inhibitors (Roche Applied Science)
were added to the suspension, and cells were lysed on ice by
sonication using four 30-s pulses with 2-min rests between each
pulse. Lysates were clarified by centrifugation at 20,000 rpm for
30 min at 4 °C in a Sorvall SS34 rotor. Protein was isolated from
the resulting supernatant by affinity chromatography using a
HisTrap HP column on an AKTA pure FPLC system (GE
Healthcare). Fractions containing His-tagged proteins were
pooled and dialyzed against 20 mM Tris, 100 mM NaCl, 5 mM
EDTA, 0.5 mM tris(2-carboxyethyl)phosphine, pH 7.7, using
Spectra/Por dialysis membrane (Spectrum Laboratories, Rancho Dominguez, CA) at 4 °C for 48 h with multiple changes to
fresh buffer. Sample purity was typically greater than 95%, as
determined by Coomassie G250-stained SDS-PAGE. Protein
concentrations were determined by UV spectroscopy using an
extinction coefficient of 18,450 M⫺1 cm⫺1. The protein stock
was aliquoted, flash-frozen in liquid nitrogen, and stored at
⫺80 °C until use. Protein yield was typically ⬎160 mg/liter of
cell culture.

Modulation of Htt-NTF aggregation via polyphasic linkage
two, or three asterisks corresponding to the following p value
cutoffs: *, p ⬍ 0.05; **, p ⬍ 0.01; ***, p ⬍ 0.001. Analyses were
implemented in Python.
Molecular simulations
All atom simulations used to parameterize our coarsegrained model were performed using the CAMPARI simulation
package utilizing the ABSINTH implicit solvation model and
force field paradigm (98, 99). Coarse-grained Langevin dynamics simulations were performed using the LAMMPS simulation
package (67). Details regarding the set-up and execution of the
simulations are given in the supporting Methods.
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C., Gharakhani, J., Jülicher, F., and Hyman, A. A. (2009) Germline P granules are liquid droplets that localize by controlled dissolution/condensation. Science 324, 1729 –1732 CrossRef Medline
9. Zhang, H., Elbaum-Garfinkle, S., Langdon, E. M., Taylor, N., Occhipinti,
P., Bridges, A. A., Brangwynne, C. P., and Gladfelter, A. S. (2015) RNA
controls PolyQ protein phase transitions. Mol. Cell 60, 220 –230 CrossRef
Medline
10. Molliex, A., Temirov, J., Lee, J., Coughlin, M., Kanagaraj, A. P., Kim, H. J.,
Mittag, T., and Taylor, J. P. (2015) Phase separation by low complexity
domains promotes stress granule assembly and drives pathological fibrillization. Cell 163, 123–133 CrossRef Medline
11. Su, X., Ditlev, J. A., Hui, E., Xing, W., Banjade, S., Okrut, J., King, D. S.,
Taunton, J., Rosen, M. K., and Vale, R. D. (2016) Phase separation of

3744 J. Biol. Chem. (2018) 293(10) 3734 –3746

22.

23.
24.

25.

26.

27.

28.

Downloaded from http://www.jbc.org/ at Washington University on March 14, 2018

Author contributions—A.E.P., K.M.R., T.S.H., and R.V.P. conceptualization; A.E.P. K.M.R., S. L. C., and A. L. data curation; A.E.P.,
K.M.R., and S.L.C., A.L. formal analysis; A.E.P., K.M.R., S.L.C., and
A.L. investigation; A.E.P. and K.M.R. visualization; A.E.P., K.M.R.,
T.S.H., S.L.C., A.L., M.I.D., and R.V.P. methodology; A.E.P., K.M.R.,
and R.V.P. writing-original draft; A.E.P., K.M.R., and R.V.P. writingreview and editing; K.M.R. and T.S.H. software; M.I.D. and R.V.P.
funding acquisition; R.V.P. resources; R.V.P. supervision; R.V.P. project administration.

12.

signaling molecules promotes T cell receptor signal transduction. Science
352, 595–599 CrossRef Medline
Banani, S. F., Lee, H. O., Hyman, A. A., and Rosen, M. K. (2017) Biomolecular condensates: organizers of cellular biochemistry. Nat. Rev. Mol.
Cell Biol. 18, 285–298 CrossRef Medline
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SUPPORTING METHODS
Peptide disaggregation: An appropriate amount of peptide was weighed in a Wheaton glass
vial and dissolved in a 1:1 mixture of trifluoroacetic acid (TFA):hexafluoroisopropanol (HFIP),
such that the final concentration was roughly 1 mg/mL peptide. The TFA-HFIP protocol was
previously shown to be reasonable for polyQ containing peptides that lack the N17 module (1,2).
This solution was sonicated for ~45 seconds and left to incubate at room temperature for 1 hour.
The solution was then thoroughly evaporated under a gentle nitrogen stream until a clear
peptide film remained on the walls of the glass vial. The peptides were resuspended from this
film in a small volume of buffer (20 mM Tris, 5 mM EDTA, 1 mM DTT) at room temperature with
sonication. The solution was then diluted to the desired concentration by the addition of buffer
and the pH was re-adjusted to 7.4. DTT was included in the buffer to reduce cysteine bonds in
profilin, but to be consistent DTT was also used in experiments that did not include profilin. For
experiments performed in the presence of profilin, an appropriate amount of a concentrated
profilin stock solution was added to the peptide after the peptide was resuspended by sonication
as described above. All chemicals were purchased from Sigma unless otherwise noted.

Steady-state tryptophan fluorescence data analysis: Using nonlinear least-squares analysis,
the data were fit to the equation F =

Fmax ⎡⎣L ⎤⎦

(K

+ ⎡⎣L ⎤⎦
d

)

where Fmax is the fluorescence maximum

recovered from fitting the raw data and [L] is the concentration of Q40-C38. The data were then
converted to fraction bound, where fraction bound is defined as: F/Fmax. The equation for
estimating F is a simplified form that is based on the assumption that the macromolecule
(profilin) concentration is not considerably larger than Kd, which is true in this case: even the
highest profilin concentration used (20 µM), is not significantly larger than the apparent Kd which
is ~10 µM. To verify that changing the profilin concentration did not have an effect on fitting with
the simplified equation, each isotherm was also fit with the full quadratic equation
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F = Fmax

( ⎡⎣M⎤⎦ + ⎡⎣L ⎤⎦ + K ) − ( ⎡⎣M⎤⎦ + ⎡⎣L ⎤⎦ + K )
d

d

2

− 4 ⎡⎣M⎤⎦ ⎡⎣L ⎤⎦

2 ⎡⎣M⎤⎦

, which includes the macromolecule

concentration ([M]) in the fit. This analysis yields values for the apparent dissociation constant
that are essentially equivalent to those obtained using the simplified fit in each instance.

Right-angle static light scattering data analysis: Optimal linear fits were determined using a
modified jackknife approach in the following manner: each dataset was subjected to two
independent series of linear fits, with one series of fits for the low concentration arm (hereafter
referred to as LCA) and the second series of fits for the high concentration arm (hereafter
referred to as HCA). For each arm (the LCA and the HCA), a series of fits was initiated with a
linear fit to the four lowest or highest concentration data points, respectively, and the root mean
square error (RMSE) of each fit was recorded. Following these initial fits, the next highest or
lowest concentration data point was added to the respective LCA or HCA data set, the
expanded data sets were re-fit, and the new RMSEs were recorded.

This process was

continued, expanding the fitted dataset by one data point at a time, until all the points in the full
dataset were included in both the LCA and HCA linear fits. Fits that included data points from
the opposite side of the putative discontinuity point caused the RMSE to deviate significantly
and could be observed on a plot of RMSE vs. number of points fit. In our case, either the mean
or the median RMSE of the fits for a given arm of the data consistently correlated with the point
at which the RMSE began to deviate significantly. Consequently, the mean or median RMSE
was used as a cutoff; all fits with an RMSE above the cutoff were discarded, and all fits with an
RMSE below the cutoff were deemed “best fits”. The intersections of each pair of LCA and HCA
best fits were recorded and the average intersection point for all best fits, for all trials at a given
concentration of profilin, were determined. This is the value reported as cS herein.

S-3

Thioflavin T fluorescence measurements: Peptides were dissolved and disaggregated in
formic acid and the solution was adjusted to 20 mM Tris buffer at pH 7.4, with 5 mM EDTA and
1 mM DTT. Note that identical results were also obtained in 50 mM phosphate buffer. Profilin
from a concentrated stock solution and / or buffer was added in the appropriate amounts to
achieve the specified final profilin concentrations while maintaining equivalent dilution of peptide
across all samples. The final concentration of ThT was 20 µM. Samples were prepared in
triplicate in 96-well plates that were subsequently covered with a transparent film to prevent
sample evaporation. Measurements were carried out at 23°C in a Tecan plate reader with 5
seconds of orbital shaking once per minute.

Samples were excited at 436 nm (20 nm

bandwidth) and emission was collected at 482 nm (28 nm bandwidth).

TEM image analysis: For size analysis of M- and S-phase particles, TEM images of Q40C38
samples at two concentrations (126 nM and 295 nM) were analyzed using a custom algorithm
implemented using ImageJ and Python. 22,384 M-phase particles and 342 S-phase particles
were sampled and histogrammed. Mean particle sizes (diameters) were determined by fitting
each histogram to a Gaussian (126 nM sample) or sum of two Gaussian curves (295 nM
sample). For the analysis of the binding of profilin to the various phases (with profilin identified
using 5 nm Ni-gold nanoparticles bound to the profilin His-tag), the custom algorithm described
above was modified to create false-colored images wherein M-, S- and F-phase aggregates
were color-coded. A 19 nm diameter cutoff was used to distinguish between M- and S-phases
and an aspect ratio cutoff of 2.0 was used to distinguish fibrils from non-fibrillar aggregates. Five
TEM images of aggregation assay samples with 16.4 µM Q40C38 and 5 µM profilin were colorcoded in this way, then the number of gold nanoparticles associated with M-, S- and F-phases
were manually counted/classified.
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All Atom Simulations: All atom simulations used to extract coarse-grained parameters were
performed using the CAMPARI simulation package (http://campari.sourceforge.net) with the
ABSINTH implicit solvation model and forcefield paradigm (3,4). The details of the ABSINTH
implicit solvation model and move sets used in the CAMPARI modeling package have been
published previously (3,5). Simulations were based on the abs3.2_opls.prm parameter set.
Temperature replica exchange was used to enhance sampling using a temperature schedule of
T=[288 K, 293 K, 298 K, 305 K, 310 K, 315 K, 320 K, 325 K, 335 K, 345 K, 360 K, 375 K, 390 K,
405 K]. Each simulation consisted of 6.15×107 steps. Steps can be either Metropolis Monte
Carlo moves or temperature swaps. The first 107 steps are taken as equilibration and all
analyses are performed over the last 5.15×107 steps. Temperature swaps were proposed every
5×104 steps. Simulations were run in spherical droplets of radius 125 Å. This radius sized was
picked in order to ensure against confinement artifacts. The specific sequences used for coarsegrained

parameterization

were

Ace-Q22-Nme,

Ace-Q40-Nme,

and

Ace-P11-

QLPQPPPQAQPLLPQPQ-P10-Nme. Here, the subscripts denote how many times that amino
acid was repeated, Ace is the N-terminal acetyl unit, and Nme is the C-terminal N-methyl amide.

Coarse-Grained Langevin Dynamics Simulations: Langevin dynamics (LD) simulations were
used to study Q40-C38:Pfn interactions. All LD simulations utilized the LAMMPS simulation
package (http://lammps.sandia.gov) (6). The force on each bead i is given by

Fi = −∇Weff,i −

mi
v + R i . (1)
γi i

Here, Weff is the effective energy function described below (Equation (2)). The second term
denotes the frictional force which is proportional to the velocity of bead i, vi. The damping term,
γi, is calculated using γ i = C

mi
. Here, mi is the mass of bead i, η=6.29 × 10-4 kg m-1 s-1 is
6πηRi

the viscosity of water at 315 K, Ri is the radius of bead i, and C=20 is a scaling factor. The last
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term in Equation (1) denotes the random force, derived from the fluctuation dissipation theorem,
exerted on bead i from collisions with the bath. The equation of motion is integrated using a
velocity Verlet algorithm with an integration time step of 2 fs.
Coarse-grained simulations of C38:Pfn and Q40-C38:Pfn interactions were performed in
the canonical ensemble with and without the presence of an auxiliary Pfn interaction.
Simulations were conducted in cubic boxes of length 703.9 Å with periodic boundary conditions.
Each simulation included 210 Pfn molecules and 630 C38 stretches. Each Q40-C38:Pfn
simulation had M Q40-C38 clusters of size X such that M×X=630. Here, X=1, 3, 6, 9, 15, 35, 70,
210. By restricting each simulation to only have clusters of a particular size, we bypass
problems associated with the kinetics of aggregation in coarse-grained simulations. Simulations
were initiated by replicating Pfn molecules and Q40-C38 clusters on three-dimensional lattices.
Following initiation, energy minimization was performed utilizing the Polak-Ribiere conjugate
gradient algorithm (6). Then, 108 steps of LD simulations are performed using a time step of 2 fs.
For each combination of Q40-C38 cluster size and auxiliary interaction 5 independent
simulations were performed.

Coarse-Grained Model Architecture: Q40-C38 clusters of size X were constructed using a
single scaled bead for the aggregated polyQ domains with X C38 stretches protruding from the
surface of the polyQ bead. Specifically, the radius of the polyQ bead was determined using the
equation Rg=R0Nν. Here, Rg is the radius of gyration, N is the number of glutamine residues in
the cluster, ν=0.33 for globules, and R0=2.85 is the pre-factor. The pre-factor R0 was determined
by fitting the <Rg> from all atom simulations of Q22 and Q40 to the equation <Rg>=R0N0.33.
The coarse-grained architecture of the C38 stretches is p-pPfn-p-l-l-l-l-l-p-pPfn-p. Here, p
denotes an excluded volume polyP bead, pPfn denotes a polyP bead that interacts with Pfn
through its primary polyP binding site, and l denotes a linker bead. Given this architecture, each
C38 bead corresponds to 3-4 amino acids. The specific sequence-to-bead mapping is given by
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(PPPP)-(PPP)-(PPPP)-(QLPQ)-(PPP)-(QAQ)-(PLL)-(PQPQ)-(PPP)-(PPP)-(PPPP), where each
set of amino acids within parentheses corresponds to a bead. The radius of each C38 bead was
determined by calculating the average Rg over the residues that make up the bead. The mass
of each bead was taken to be the sum of the mass of the amino acids that make up the bead.
The base coarse-grained architecture for Pfn is an excluded volume bead (PfnEV) and a
polyP interacting bead (Pfnp). The radius of the PfnEV bead was taken to be the Rg extracted
from the crystal structure of human Pfn 1 (PDB: 1pfl). The radius of the Pfnp bead was taken to
be that of the C38 pPfn bead. The mass of the Pfnp bead was taken to be that of the C38 pPfn
bead (291.39 g/mol) and the rest of the Pfn mass was distributed to the PfnEV bead. In order to
model the linker:Pfn and Pfn:Pfn auxiliary interactions an additional coarse-grained Pfn bead
was added to the Pfn model. The details of these additions are discussed below.

Coarse-Grained Model Energy Function: The coarse-grained energy function takes the form:

Weff = Wb + Wθ + WLJ + WPrimary + WAuxiliary . (2)
Here, Wb, Wθ, WLJ, WPrimary, and WAuxiliary correspond to the bond length, bond angle, LennardJones, primary, and auxiliary interaction potentials. The primary interaction potential refers to
the interaction between Pfn and polyP. The auxiliary interaction potential refers to the interaction
between Pfn and either polyQ, linker, or Pfn.
The bonded potentials in Equation (2) are given by
Nb

Wb = ∑
i=1
Nθ

Wθ = ∑
i=1

K i ( bi − b0i )

2

,

2
Li ( θi − θ0i )
2

2

.

Here, Nb and Nθ are the total number of bonds and angles in the system and Ki and Li are the
force constants associated with the equilibrium bond and angle values given by b0i and θ0i,
respectively. The Boltzmann inversion procedure (7) was used to extract Ki, Li, b0i, and θ0i for
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C38 beads from all atom simulations of C38 at 315 K. Given that the bonded potentials are
described by harmonic potentials, inversion of the Boltzmann relationship yields the following
analytical relationships for Ki, Li, b0i, and θ0i

b0i = bi , K i =
θ0i = θi , L i =

k BT
b − bi
2
i

2

,

k BT
θ2i − θi

2

.

Here, bi and θi are the sets of bond lengths and bond angles extracted from the all atom
simulations. For the bond between the polyQ bead and the first C38 bead, b0i and Ki were set to
the radius of the polyQ bead and 10 kcal/mol/Å2, respectively. For the bond between the two
Pfn beads, b0i and Ki were set to the sum of the radii of the two Pfn beads and 10 kcal/mol/Å2,
respectively. Finally, θ0i and Li were set to 180 degrees and 10 kcal/mol/radians2, respectively,
for the angle between the polyQ bead and the first two C38 beads.
The WLJ term, denotes the Lennard-Jones potential calculated over non-bonded pairs of
beads with the form

WLJ

⎡⎛ σ ⎞ 12 ⎛ σ ⎞ 6 ⎤
= ∑ ∑ 4ε ij ⎢⎜ ij ⎟ − ⎜ ij ⎟ ⎥, rij < rc
⎢⎝ rij ⎠
i=1 j<i
⎝ rij ⎠ ⎥
⎣
⎦
= 0, rij ≥ rc .
N nb

Here, Nnb is the number of beads, rij is the distance between beads i and j, σij is the distance at
which the inter-bead potential is zero, and εij is the strength of the interaction. Except for the
primary and auxiliary interactions between Q40-C38 clusters and Pfn molecules described in

(

)

detail below, all non-bonded inter-bead interactions were defined by σ ij = 2Rgi + 2Rgj / 2 Å,
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where Rgi is the Rg extracted from all atom simulations or the Pfn crystal structure for bead i as
explained above, εij=0.01 kcal/mol, and rc = 2.5σ ij Å.
The primary interaction potential models the interaction between Pfn and polyP. In order
to model this interaction, we combined inverted Gaussian (wG) and Lennard-Jones (wLJ)
potentials. Explicitly,

WPrimary

=

wG + wLJ ,
Np

=

wG

Pfn

∑

N Pfn

i=1

=

0, rij ≥ rGcutoff ,
N p,p

=

wLJ

⎡ (rij − rG )2 ⎤
−ε
exp
∑ G ⎢ − 2σ 2 ⎥, rij < rGcutoff
j=1
⎢⎣
⎥⎦
G
p

Pfn

N Pfn

EV

∑ ∑
i=1

j=1

12
6
⎡⎛
⎞
⎛σ ⎞ ⎤
σ
4ε LJ ⎢⎜ LJ ⎟ − ⎜ LJ ⎟ ⎥, rij < rLJcutoff
⎢⎝ rij ⎠
⎝ rij ⎠ ⎥
⎣
⎦

= 0, rij ≥ rLJcutoff .
Here, N p , N Pfn , N p, p , and N Pfn
p
Pfn

Pfn

EV

correspond to the number of pPfn beads, the number of

Pfnp beads, the number of p and pPfn beads, and the number of PfnEV beads, respectively. For
wG, rij is the distance between beads i and j, εG = 6 kcal/mol is the interaction strength, rG = 0 Å is
cutoff
= 2.5R
the position of the well, σG = 2.27 Å controls the width of the well, and rG

pPfn

, where

R pPfn is the radius of the C38 pPfn bead. The width of the well was chosen such that the energy
for two pPfn beads to bind the Pfnp bead on a single Pfn molecule was half that of the energy for
a single pPfn bead to bind the Pfnp bead. This choice was made in order to disfavor a single Pfnp
from binding multiple pPfn beads. Explicitly, in the dimer case rp

Pfn ,Pfn p

where Rg is the radius of the pPfn bead. This yields
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= Rg since σ p

Pfn , pPfn

= 2Rg ,

1
U = UD,
2 M
⎛ Rg 2 ⎞ (3)
⎛ 02 ⎞
1
− ε G exp ⎜ − 2 ⎟ = −2ε G exp ⎜ − 2 ⎟ .
2
⎝ 2σ G ⎠
⎝ 2σ G ⎠
Rearranging Equation (3), yields

σG =

− Rg2
⎛ 1⎞
2ln ⎜ ⎟
⎝ 4⎠

= 2.27Å

For wLJ, rij is the distance between beads i and j, εLJ = 0.01 kcal/mol is the interaction strength,
σLJ is the distance at which the inter-bead potential is zero, and rLJcutoff = 2.5σ LJ . Here, σLJ was
set to the radius of the PfnEV bead. This choice prevented excluded volume effects between
PfnEV beads and p and pPfn beads from disfavoring pPfn:Pfnp interactions.
The auxiliary interaction potential takes on three different forms for the three different
models tested to account for the experimental observations. The three models are a polyQ:Pfn
interaction, a linker:Pfn interaction, and a Pfn:Pfn interaction. The details of each model will be
discussed below.
The auxiliary interaction potential for the polyQ:Pfn interaction is modeled as a LennardJones potential between the polyQ bead and the PfnEV bead. Long polyQ stretches and polyQ
aggregates have been shown to interact non-specifically with other molecules (8-10). Thus, we
assumed that the polyQ cluster should be uniformly and non-specifically interactive with Pfn.
Explicitly, the model takes the form

polyQ:Pfn
WAuxiliary

=

N polyQ N Pfn EV

∑ ∑
i=1

j=1

12
6
⎡⎛ σ
⎤
⎞
⎛
⎞
σ
polyQ:Pfn
polyQ:Pfn
cutoff
⎢
4ε polyQ:Pfn ⎜
−⎜
⎟ ⎥⎥ , rij < rpolyQ:Pfn
⎢⎝ rij ⎟⎠
r
⎝
⎠
(4)
ij
⎣
⎦

cutoff
= 0, rij ≥ rpolyQ:Pfn
.
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In Equation (4), N polyQ and N Pfn

EV

denote the number of polyQ and PfnEV beads, respectively, rij

is the distance between beads i and j, ε polyQ:Pfn is the strength of the interaction, which was set to
either 1 or 2 kcal/mol, and σ polyQ:Pfn = R polyQ Å is the distance at which the inter-bead potential is
zero. Here, R

polyQ

cutoff
is the radius of the polyQ bead. The cutoff, rpolyQ:Pfn
, was set to 2.5σ polyQ:Pfn .

For the linker:Pfn auxiliary interaction potential an additional bead was added to the Pfn
architecture. This bead, termed Pfnlinker, was set to have the same mass and radius as the Pfnp
bead. The rest of the mass was distributed to the PfnEV bead. The linker:Pfn interaction potential
is modeled as a Lennard-Jones potential between the Pfnlinker bead and all non-polyP linker
beads, with the addition of bond length and angle terms to account for the extra Pfn bead.
Specifically,
linker:Pfn
WAuxiliary

linker:Pfn
b

w

=
=

linker:Pfn
wblinker:Pfn + wθlinker:Pfn + wLJ
,
N Pfn

∑

K i ( bi − b0i )

w

linker:Pfn
LJ

w

=

N Pfn

∑

Li ( θi − θ0i )
2

i=1

=

N linker N Pfnlinker

∑ ∑
i=1

=

,

2

i=1

linker:Pfn
θ

2

j=1

2

,

(5)

12
6
⎡⎛
⎞
⎛ σ linker:Pfn ⎞ ⎤
σ
linker:Pfn
⎥ , r < r cutoff
4ε linker:Pfn ⎢⎜
−⎜
⎟
⎟
ij
linker:Pfn
⎢⎝ rij ⎠
⎝ rij ⎠ ⎥
⎣
⎦

cutoff
0, rij ≥ rlinker:Pfn
.

Here, N Pfn , N linker and N Pfn

linker

denote the number of Pfn molecules, non-polyP linker beads,

linker:Pfn
and Pfnlinker beads, respectively. For wLJ
, rij is the distance between beads i and j, ε linker:Pfn

is the strength of the interaction, which was set to either 1, 1.5, or 2 kcal/mol, and

(

σ linker:Pfn = 2R

Pfn linker

)

+ 2R l / 2 Å is the distance at which the inter-bead potential is zero. Here,
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R

Pfn linker

l

cutoff
and R are the radii for the Pfnlinker and l beads, respectively. The cutoff, rlinker:Pfn
, was set

to 2.5σ linker:Pfn .
In Equation (5), wblinker:Pfn and wθlinker:Pfn account for the bond length and bond angle
potentials between Pfnlinker:PfnEV beads and Pfnp:PfnEV:Pfnlinker beads, respectively. The
equilibrium bond length (b0i) and force constant (Ki) between Pfnlinker and PfnEV were set to the
sum of the radii of the two Pfn beads and 10 kcal/mol/Å2, respectively. The equilibrium angle
(θ0i) and force constant (Li) between all three Pfn beads were set to 180 degrees and 10
kcal/mol/radians2, respectively. This architecture was chosen to account for the experimental
observation that the Kd for the C38:Pfn interaction is twice that of the Kd for the P11:Pfn
interaction. This result implies the linker does not engage in interactions with the same Pfn
molecule that interacts with one of the two polyP segments within C38. Thus, in order to be
consistent with experimental results, if the linker was to interact with Pfn, then it would have to
interact on the opposite face of the polyP binding pocket. This architecture restricts the linker
and a polyP segment of the same C38 from interacting with the same Pfn molecule. Additionally,
the opposite face of the polyP binding pocket on Pfn is enriched in polar residues which may
engage in interactions with the polar and hydrophobic residues of the linker (11).
For the Pfn:Pfn auxiliary interaction, stable Pfn dimers were created to bypass kinetic
problems associated with Pfn:Pfn dimerization. To construct stable Pfn dimers an additional Pfn
bead, Pfndimer, was added to the architecture (see Figure S6). Pfndimer was set to have the same
mass and radius as the Pfnp bead. The rest of the mass was distributed to the PfnEV bead. The
Pfn:Pfn auxiliary potential contains bond length, bond angle, and Lennard-Jones potentials in
order to account for the stable dimer architecture. Specifically,
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Pfn:Pfn
WAuxiliary

Pfn:Pfn
b

w

=
=

Pfn:Pfn
wbPfn:Pfn + wθPfn:Pfn + wLJ
,
N bPfn:Pfn

∑

K i ( bi − b0i )

w

=

N θPfn:Pfn

∑

Li ( θi − θ0i )

w

p

∑

=

i=1

=

2

2

i=1

,

(6)

12
6
⎡⎛
⎞
⎛ σ Pfn:Pfn ⎞ ⎤
σ
cutoff
Pfn:Pfn
∑ 4ε Pfn:Pfn ⎢⎢⎜ r ⎟ − ⎜ r ⎟ ⎥⎥ , rij < rPfn:Pfn
j<i
⎝ ij ⎠
⎝ ij ⎠
⎣
⎦

N Pfn N Pfn
Pfn:Pfn
LJ

,

2

i=1

Pfn:Pfn
θ

2

p

cutoff
0, rij ≥ rPfn:Pfn
.

Here, N bPfn:Pfn and N θPfn:Pfn are the number of new bond lengths and bond angles that need to be
defined in order to create a stable dimer, respectively.

The new bonds defined are

m1
m2
m1
m2
, Pfn m2
, and Pfn dimer
. Here, m1 and m2 correspond to molecule
Pfn m1
: Pfn dimer
: Pfn dimer
: Pfn dimer
EV
EV

1 and molecule 2, respectively. The equilibrium bond length (b0i) and force constant (Ki)
m1
m2
m1
m2
between Pfn m1
, Pfn m2
, and Pfn dimer
were set to 6.47 Å and 10
: Pfn dimer
: Pfn dimer
: Pfn dimer
EV
EV

kcal/mol/Å2,

respectively.

m1
m2
.
Pfn dimer
: Pfn dimer
: Pfn m2
EV

The
The

new

angles

equilibrium

defined

angle

(θ0i)

are
and

m1
m2
Pfn m1
: Pfn dimer
: Pfn dimer
EV

force

constant

(Li)

and
for

m1
m2
m1
m2
and Pfn dimer
were set to 180 degrees and 10
Pfn m1
: Pfn dimer
: Pfn dimer
: Pfn dimer
: Pfn m2
EV
EV

kcal/mol/radians2, respectively. These choices allow for the distance between the two Pfnp
beads of a dimer to vary while the distance between the two PfnEV beads is held relatively fixed.
We allow for variability in the distance between the two Pfnp beads since the site of Pfn
dimerization is not known. However, in order to restrict the two Pfnp beads from coming too
close we changed the Lennard-Jones potential parameters between two Pfnp beads. The
Pfn:Pfn
Lennard-Jones potential between two Pfnp beads is defined by wLJ
in Equation (6). Here,

N Pfn is the number of Pfnp beads, rij is the distance between beads i and j, ε Pfn:Pfn = 0.01
p
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kcal/mol is the strength of the interaction, σ Pfn,Pfn = 10 Å is the distance at which the inter-bead
cutoff
potential is zero, and rPfn:Pfn
= 2.5σ Pfn:Pfn .

Calculation of Fraction Bound from Simulations: In order to determine which Q40-C38
clusters Pfn preferentially bound, the fraction of Pfnp beads bound to C38 pPfn beads was
calculated. We only consider this interaction in our calculation given that this is the interaction
the steady-state tryptophan fluorescence experiments measure. A Pfnp bead was said to be
bound to a C38 pPfn bead if the distance between the two beads was less than 2R

pPfn

, where

R pPfn is the radius of the pPfn bead. The fraction bound for a given simulation was averaged over
the last 38.2 ns of the simulation, i.e., the post-equilibration time.
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SUPPORTING FIGURES AND TABLE

-0.2

N17-Q72* + Pfn(S137A)

N17-Q72*

N17-Q72* + Pfn(S137D)

-0.15

N17-Q72* + Pfn

-0.1

N17-Q72-C38* + Pfn(S137A)

-0.05

N17-Q72-C38* + Pfn(S137D)

0.00

N17-Q72-C38* + Pfn

Relative FRET to monitor aggregation

0.05

-0.25

-0.3

Figure S1: The C38 region is required for modulation of Htt-NTF aggregation by profilin.
FRET-based intracellular aggregation assay. All constructs have either a CFP or YFP fused to
the C-terminus as denoted by the asterisk. The bar heights quantify the relative FRET, which is
defined as (∆F/Fref) where ∆F=(FX–Fref). Here, FX is the intracellular FRET for the construct in
question and Fref is the FRET measured for N17-Q72-C38-CFP/YFP in the absence of profilin.
The green bars are data for Htt-NTF constructs without the C38 module. The more negative the
bars, the stronger the suppressive effects of profilin. Wild type profilin reduced N17-Q72-C38CFP/YFP aggregation by 30%, as described previously (12). However, the aggregation of N17Q72-CFP/YFP was unaffected by profilin overexpression (first and second green bars). The
ability to suppress intracellular aggregation by profilin was blocked by the phosphomimic
mutation S137D and was preserved by the S137A mutation (second and third gray bars,
respectively) whereas these mutations had no effects on constructs lacking C38 (third and
fourth green bars). Pfn refers to profilin whereas Pfn(S137D) and Pfn(S137A) refer to variants of
profilin with Ser 137 replaced by Asp or Ala to mimic phosphorylation or non-phosphorylation,
respectively.

S-15

126 nM

Probability Density

0.06

295 nM
0.04

0.02

0.00
0

10

20

30

40

50

Diameter (nm)

Figure S2:

Aggregate size distributions determined by analysis of TEM images.

Histograms of Q40-C38 particle/aggregate sizes observed at 126 nM (M-phase, red) and at 295
nM (S-phase, blue), quantified using a custom image analysis algorithm. The raw histograms
are shown as lighter shades of each color, while fits to Gaussian curves are shown as darker
shades. The histograms represent the value of the probability density function at each bin (bin
size = 1 nm), normalized such that the integral over the range is 1. 22,384 M-phase particles
and 342 S-phase particles were sampled for the histograms and the sizes of particles at these
two concentrations were found to be distinct, with a mean particle size of 13.83 +/- 0.06 for the
single peak from the 126 nM sample (red), and 9.53 +/- 0.83 and 23.94 +/- 0.24 for the two
peaks from the 295 nM sample (blue). Mean particle sizes were determined by fitting each
histogram to a Gaussian (126 nM sample) or sum of two Gaussian curves (295 nM sample).
The two peaks from the 295 nM sample likely represent M- and S-phase species, respectively.
Quantification of the monomer and small oligomer sizes are likely a significant overestimate
because monomers and some small oligomers approach the size of one or a few pixels and are
therefore unavoidably filtered out as noise by the image analysis algorithm.
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Figure S3. Profilin binds the polyP tracts in the C38 region of Htt-NTFs. (a) Binding
isotherms of profilin with P11 (purple) or C38 (black) peptides. Fits to the data yield apparent Kd
values of 106.5 µM and 50.7 µM, respectively. (b) When the peptide concentration is adjusted
to reflect the concentration of polyP tracts (P11 is a single tract, whereas C38 contains two polyP
tracts), then the binding isotherms overlay, indicating that the difference in apparent Kd is due
solely to the number of binding sites. The profilin concentration was 5 µM.
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a
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c
C38

Q40-C38 Q -C38
40
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e

P11

C38

Q40-C38

Figure S4. Hill and Scatchard analyses of profilin/P11, profilin/C38 and profilin/Q40-C38
binding. (a, b, c) Hill analyses of profilin/peptide binding with corresponding linear fits. The
analyses of four independent trials for profilin/P11 and profilin/C38 are shown to demonstrate
reproducibility. (a) Profilin/P11 served as a control since it only has a single binding site, and this
was confirmed by the slope of each of the four trials being essentially equal to one. (b) For
profilin/C38, the slope of each of the four trials was also essentially equal to one, indicating a
lack of cooperativity between the polyproline modules in C38. (c) The slopes of Q40-C38 trials
were near one, but the fits were less robust, as can be seen in the selected fit (one trial that is
representative of the other independent Q40-C38 trials). (d, e, f) Given this less than optimal fit,
we also performed a Scatchard analysis for clarification. (d) A linear (as opposed to concave)
trend in a Scatchard analysis is indicative of the absence of cooperativity between binding sites,
as can be seen in the P11 control. (e) The Scatchard analysis and corresponding linear fits of
profilin/C38 confirm the absence of cooperativity between polyproline binding sites in C38. (f)
The profilin/Q40-C38 Scatchard plot exhibits a clear concave-down shape and intersection with
the origin, which together are indicative of positive cooperativity.

S-18

The red line is drawn to

highlight these characteristics. In all of the panels, “B” refers the concentration of bound species,
“P” is the concentration of Profilin, and “Lfree” is the concentration of free (unbound) ligand (i.e.,
peptide).

a

b
Q30-C38

c

N17-Q30-C38

d

Q30-C38

N17-Q30-C38

Figure S5. Hill and Scatchard analyses of profilin/Q30-C38 and profilin/N17-Q30-C38
binding. Hill (a, b) and Scatchard (c, d) analyses were carried out for the binding of profilin to
Q30-C38 and N17-Q30-C38. (a, b) The Hill analysis gives a less than optimal linear fit for
profilin/Q30-C38 and profilin/N17-Q30-C38, respectively.

Similar results were obtained for

additional trials, but a single representative trial is shown for the sake of clarity. (c, d) Scatchard
analysis of profilin/Q30-C38 and profilin/N17-Q30-C38, respectively, shows clear downward
concavity and intersection with the origin (again in both cases) consistent with cooperative
binding. The red line is drawn to highlight these characteristics. Similar results were obtained
for additional trials, but a single representative trial is shown for the sake of clarity. In all of the
panels, “B” refers the concentration of bound species, “P” is the concentration of Profilin, and
“Lfree” is the concentration of free (unbound) ligand (i.e., peptide).
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Figure S6: Test of three distinct auxiliary interaction models by coarse-grained
simulations. (a, b, c) Visual representations of the architectures used for the polyQ:Pfn,
linker:Pfn, and Pfn:Pfn auxiliary interaction models, respectively. Pfn and Q40-C38 molecules
are represented by a set of coarse-grained beads connected by flexible springs. Each bead type
is defined in the left legend. Model details are described in the Methods section. (d, e, f)
Fraction of profilin molecules bound to a polyP site through the primary Pfn:PolyP interaction for
the polyQ:Pfn, linker:Pfn, and Pfn:Pfn auxiliary interaction models, respectively. Each bar
denotes the fraction bound for a simulation consisting of M Q40-C38 clusters of size X such that
M x X=630, where X=1, 3, 6, 9, 15, 35, 70, or 210 (see Methods for details). The bar colors
correspond to the cluster sizes given by the corresponding colors in the right legend. Error bars
denote the standard error of mean calculated over five independent simulations. A cluster size
of 0 indicates a C38 molecule without the polyQ domain. For the polyQ:Pfn and linker:Pfn
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auxiliary interaction models the strength of the auxiliary interaction potential is given in kcal/mol
below each plot. For the Pfn:Pfn auxiliary interaction model, the auxiliary Pfn:Pfn interaction is
modeled by creating a bond between two Pfn beads (see Methods). Only the polyQ:Pfn
auxiliary interaction model is found to be consistent with the two experimental results: (1) cS
shifts to higher concentrations in the presence of Pfn, which implies as Q40-C38 cluster sizes
become larger, Pfn binding must become weaker, and (2) Kd of Pfn binding C38 decreases for
Q40-C38 compared to C38, which implies Pfn must bind Q40-C38 clusters better than C38.

Pfn m1
EV

Pfn m1
p

Pfn m2
EV

m1
Pfn dimer

m2
Pfn dimer

Pfn m2
p

Figure S7: Pfn:Pfn dimerization architecture. Here, dark blue circles correspond to PfnEV
beads, light blue circles correspond to Pfnp beads, and red circles correspond to Pfndimer beads.
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Table S1 – Measured values of cS and dissociation constants (Kd) for peptide constructs
as a function of profilin concentration
Profilin concentration (µM)
cS

Kd

0

1

5

10

20

Q40-C38

0.2948 ± 0.1

3.2 ± 0.4

4.3 ± 1.0

6.4 ± 0.7

6.3 ± 3.3

Q40-C38

-

11.6 ± 2.2

8.8 ± 1.7

5.6 ± 1.4

5.4 ± 1.0

C38

-

-

50.7 ± 3.5

-

-

P11

-

-

106.5 ± 9.1

-

-

Q30-C38

-

-

20.5± 2.7

-

-

N17-Q30-C38

-

-

5.9 ± 1.3

-

-

All values in units of µM ± standard deviation for 3 - 4 independent trials
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